Atlas Trials

Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization

Clinical trial NCT00434109 · COMPLETED

Trial details

NCT number
NCT00434109
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine TumorIslet Cell Tumor
Start date
2006-11-01
Primary completion
2012-02-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.